Retrospective Study
Copyright ©The Author(s) 2023.
World J Hepatol. Apr 27, 2023; 15(4): 564-576
Published online Apr 27, 2023. doi: 10.4254/wjh.v15.i4.564
Table 2 Trends of outcomes for non-alcoholic fatty liver disease hospitalizations with peptic ulcer disease in the United States from 2009-2019
Outcome
Years
Pvalue
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Inpatient mortality (%)21222214455< 0.001
Gender-specific inpatient mortality (%)0.2
Male2521285753384037523231
Female7579724347626063484848
Race-specific inpatient mortality (%)0.4
White8153894879737371816164
Black7001404044611
Hispanic12471119161971781914
Asian000105004036
Native American00050070436
Others000504134460
Age-group specific inpatient mortality (%)0.1
18-3470000300000
35-491326161301714922146
50-645136333129343641523148
65-792824365671415050264845
≥ 800131400300030
Length of stay (d)17.1 ± 0.5911.8 ± 0.7616.3 ± 0.589.2 ± 0.859.0 ± 0.018.2 ± 0.6810.1 ± 0.339.6 ± 0.4917.3 ± 0.339.2 ± 0.9011.2 ± 0.220.06
Total hospital charge ($)182296 ± 760104265 ± 620215085 ± 130172837 ± 170157079 ± 890105031 ± 760136876 ± 800134573 ± 730373045 ± 450143284 ± 940174044 ± 5500.8
Complications (%)
Bleeding02100510717710110.4
Perforation33123529163131711380.02